198 related articles for article (PubMed ID: 28942916)
1. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients.
Carrieri MP; Protopopescu C; Marcellin F; Rosellini S; Wittkop L; Esterle L; Zucman D; Raffi F; Rosenthal E; Poizot-Martin I; Salmon-Ceron D; Dabis F; Spire B;
J Hepatol; 2017 Dec; 67(6):1157-1167. PubMed ID: 28942916
[TBL] [Abstract][Full Text] [Related]
2. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
[TBL] [Abstract][Full Text] [Related]
3. HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort).
Santos ME; Protopopescu C; Sogni P; Yaya I; Piroth L; Bailly F; Marcellin F; Esterle L; Wittkop L; Rosenthal E; Morlat P; Roux P; de Araujo WN; Salmon-Ceron D; Carrieri MP;
AIDS Behav; 2020 Apr; 24(4):1069-1084. PubMed ID: 31286317
[TBL] [Abstract][Full Text] [Related]
4. Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS HEPAVIH CO-13 Cohort).
Yaya I; Marcellin F; Costa M; Morlat P; Protopopescu C; Pialoux G; Santos ME; Wittkop L; Esterle L; Gervais A; Sogni P; Salmon-Ceron D; Carrieri MP;
Nutrients; 2018 May; 10(6):. PubMed ID: 29857547
[TBL] [Abstract][Full Text] [Related]
5. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH).
Nordmann S; Vilotitch A; Roux P; Esterle L; Spire B; Marcellin F; Salmon-Ceron D; Dabis F; Chas J; Rey D; Wittkop L; Sogni P; Carrieri P;
J Viral Hepat; 2018 Feb; 25(2):171-179. PubMed ID: 28984055
[TBL] [Abstract][Full Text] [Related]
6. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
van der Helm J; Geskus R; Sabin C; Meyer L; Del Amo J; Chêne G; Dorrucci M; Muga R; Porter K; Prins M;
Gastroenterology; 2013 Apr; 144(4):751-760.e2. PubMed ID: 23266560
[TBL] [Abstract][Full Text] [Related]
7. Elevated Fatty Liver Index as a Risk Factor for All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study).
Barré T; Protopopescu C; Bani-Sadr F; Piroth L; Rojas Rojas T; Salmon-Ceron D; Wittkop L; Esterle L; Sogni P; Lacombe K; Chas J; Zaegel O; Chaix ML; Miailhes P; Serfaty L; Marcellin F; Carrieri MP;
Hepatology; 2020 Apr; 71(4):1182-1197. PubMed ID: 31466125
[TBL] [Abstract][Full Text] [Related]
8. Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
Shili-Masmoudi S; Sogni P; de Ledinghen V; Esterle L; Valantin MA; Poizot-Martin I; Simon A; Rosenthal E; Lacombe K; Pialoux G; Bouchaud O; Gervais-Hasenknoff A; Goujard C; Piroth L; Zucman D; Dominguez S; Raffi F; Alric L; Bani-Sadr F; Lascoux-Combe C; Garipuy D; Miailhes P; Vittecoq D; Duvivier C; Aumaître H; Neau D; Morlat P; Dabis F; Salmon D; Wittkop L;
PLoS One; 2019; 14(1):e0211286. PubMed ID: 30682180
[TBL] [Abstract][Full Text] [Related]
9. No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).
Marcellin F; Lions C; Rosenthal E; Roux P; Sogni P; Wittkop L; Protopopescu C; Spire B; Salmon-Ceron D; Dabis F; Carrieri MP;
Drug Alcohol Rev; 2017 Mar; 36(2):227-238. PubMed ID: 27073179
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems.
Fuster D; Cheng DM; Quinn EK; Nunes D; Saitz R; Samet JH; Tsui JI
Addiction; 2014 Jan; 109(1):62-70. PubMed ID: 24112091
[TBL] [Abstract][Full Text] [Related]
11. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.
Piroth L; Wittkop L; Lacombe K; Rosenthal E; Gilbert C; Miailhes P; Carrieri P; Chas J; Poizot-Martin I; Gervais A; Dominguez S; Neau D; Zucman D; Billaud E; Morlat P; Aumaitre H; Lascoux-Combe C; Simon A; Bouchaud O; Teicher E; Bani-Sadr F; Alric L; Vittecoq D; Boué F; Duvivier C; Valantin MA; Esterle L; Dabis F; Sogni P; Salmon D;
J Hepatol; 2017 Jul; 67(1):23-31. PubMed ID: 28235612
[TBL] [Abstract][Full Text] [Related]
13. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
Klein MB; Rollet KC; Saeed S; Cox J; Potter M; Cohen J; Conway B; Cooper C; Côté P; Gill J; Haase D; Haider S; Hull M; Moodie E; Montaner J; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall M; Walmsley S;
HIV Med; 2013 Jan; 14(1):10-20. PubMed ID: 22639840
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.
Billa O; Chalouni M; Salmon D; Poizot-Martin I; Gilbert C; Katlama C; Neau D; Chas J; Morlat P; Lacombe K; Naqvi A; Barange K; Gervais A; Bouchaud O; Rosenthal E; Lascoux-Combe C; Garipuy D; Alric L; Dominguez S; Vittecoq D; Goujard C; Duvivier C; Aumaitre H; Miailhes P; Zucman D; Simon A; Lazaro E; Raffi F; Esterle L; Wittkop L; Bani-Sadr F;
PLoS One; 2018; 13(12):e0208657. PubMed ID: 30562358
[TBL] [Abstract][Full Text] [Related]
15. Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH).
Antwerpes S; Protopopescu C; Morlat P; Marcellin F; Wittkop L; Di Beo V; Salmon-Céron D; Sogni P; Michel L; Carrieri MP; The Anrs Co Hepavih Study Group
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32825538
[TBL] [Abstract][Full Text] [Related]
16. Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH).
Barré T; Rojas Rojas T; Lacombe K; Protopopescu C; Poizot-Martin I; Nishimwe ML; Zucman D; Esterle L; Billaud E; Aumaitre H; Bouchaud O; Rey D; Piroth L; Salmon-Ceron D; Wittkop L; Sogni P; Carrieri MP; Serfaty L; Marcellin F
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1147-1156. PubMed ID: 33538612
[No Abstract] [Full Text] [Related]
17. Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
Dold L; Ahlenstiel G; Althausen E; Luda C; Schwarze-Zander C; Boesecke C; Wasmuth JC; Rockstroh JK; Spengler U
PLoS One; 2015; 10(8):e0134158. PubMed ID: 26241854
[TBL] [Abstract][Full Text] [Related]
18. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
[TBL] [Abstract][Full Text] [Related]
19. Overall and cause-specific excess mortality in HIV-positive persons compared with the general population: Role of HCV coinfection.
Alejos B; Hernando V; Iribarren J; Gonzalez-García J; Hernando A; Santos J; Asensi V; Gomez-Berrocal A; Del Amo J; Jarrin I;
Medicine (Baltimore); 2016 Sep; 95(36):e4727. PubMed ID: 27603368
[TBL] [Abstract][Full Text] [Related]
20. Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).
Marcellin F; Lions C; Winnock M; Salmon D; Durant J; Spire B; Mora M; Loko MA; Dabis F; Dominguez S; Roux P; Carrieri MP;
Addiction; 2013 Jul; 108(7):1250-8. PubMed ID: 23421419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
